[][com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=55018]], camposKey:0213-005X 2019-01-01 Epidemiological surveillance and wild-type MIC distribution of Legionella pneumophila in north-western Spain. 2003¿2016514520, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41231]], camposKey:0213-005X 2019-01-01 Epidemiological surveillance and wild-type MIC distribution of Legionella pneumophila in north-western Spain. 2003-2016 Vigilancia epidemiológica y distribución de CMIs de cepas salvajes de Legionella pneumophila en el noroeste de España. 2003-2016514520, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=61170]], camposKey:1075-9964 2019-01-01 High delayed mortality after the first episode of Clostridium difficile infection9398, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=42698]], camposKey:0213-005X 2019-01-01 Thermotherapy in calcaneal infection due to Prototheca wickerhamii6262, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41230]], camposKey:0934-9723 2018-04-01 Usefulness of a single-assay chemiluminescence test (Tularaemia VIRCLIA IgG + IgM monotest) for the diagnosis of human tularemia. Comparison of five serological tests643649, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=61171]], camposKey:0924-8579 2018-01-01 Prediction of recurrent clostridium difficile infection at the bedside: the GEIH-CDI score393398, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=42697]], camposKey:0213-005X 2017-01-01 Bacteremia due to Cellulosimicrobium cellulans associated with central catheter for hemodialysis6263, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41232]], camposKey:0213-005X 2016-06-01 Use of MALDI-TOF in the rapid diagnosis of sepsis Utilización de MALDI-TOF en el diagnóstico rápido de la sepsis1925, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=42657]], camposKey:0213-005X 2016-01-01 A two-hour antibiotic susceptibility test by ATP-bioluminescence334339, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=22706]], camposKey:0213-005X 2016-01-01 Antibiograma rápido en Microbiología Clínica6168, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=17239]], camposKey:1134-282X 2016-01-01 Diferencias entre las recomendaciones y la práctica clínica en la infección por Clostridium difficile152158, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=16540]], camposKey:1888-4008 2016-01-01 Evaluación del analizador de orinas Sysmex UF-1000i como método de cribado en el diagnóstico de la infección del tracto urinario38, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=42344]], camposKey:1888-4008 2016-01-01 Evaluation of urine analyzer Sysmex UF-1000i as a screening method in the diagnosis of urinary tract infection Evaluación del analizador de orinas Sysmex UF-1000i como método de cribado en el diagnóstico de la infección del tracto urinario38, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=28266]], camposKey:0025-7753 2016-01-01 Las insulinas basales más recientes, ¿realmente son más novedosas?297299, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=58704]], camposKey:0213-005X 2016-01-01 Rapid antibiotic susceptibility test in Clinical Microbiology6168, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41233]], camposKey:0167-7012 2015-12-01 A meta-analysis of in vitro antibiotic synergy against Acinetobacter baumannii3136, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=83408]], camposKey:0214-3429 2015-10-01 A two-hour procedure for determining the susceptibility of enterococci and staphylococci to antibiotics by a colourimetric method247255, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41234]], camposKey:0167-7012 2015-02-01 A new approach to determine the susceptibility of bacteria to antibiotics directly from positive blood culture bottles in two hours4955, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=17253]], camposKey:0213-005X 2015-01-01 Estudio multicéntrico sobre la actividad in vitro de ceftarolina frente a Staphylococcus aureus aislados en España101104, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=17244]], camposKey:0213-005X 2015-01-01 New procedure for rapid identification of microorganisms causing urinary tract infection from urine samples by mass spectrometry (MALDI-TOF).Nuevo procedimiento para la identificación rápida en muestras de orina de organismos causantes de infecciones del tracto urinario por espectometría de masas (MALDI-TOF)8994, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=16541]], camposKey:0214-3429 2015-01-01 Un procedimiento de dos horas para determinar la sensibilidad de estaficolococos y enterococos a los antibióticos en dos horas mediante un método colorimétrico247255, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=43249]], camposKey:0903-4641 2014-01-01 Procedure for microbial identification based on Matrix-Assisted Laser Desorption/Ionization-Time of Flight Mass Spectrometry from screening-positive urine samples790795, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41235]], camposKey:1078-5884 2014-01-01 Role of calcifying nanoparticle in the development of hyperplasia and vascular calcification in an animal model640646, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=17250]], camposKey:0213-005X 2014-01-01 Sugerencias sobre el análisis molecular microbiológico post mortem405406, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=58703]], camposKey:0934-9723 2013-05-01 A differential centrifugation protocol and validation criterion for enhancing mass spectrometry (MALDI-TOF) results in microbial identification using blood culture growth bottles699704, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=56139]], camposKey:0214-3429 2013-01-01 The situation and management of Clostridium difficile infection in Spain: an opinion document261286, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41237]], camposKey:1567-1348 2012-12-01 Clonal nature and diversity of resistance, toxins and adhesins genes of meticillin-resistant Staphylococcus aureus collected in a Spanish hospital17511758, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41238]], camposKey:0095-1137 2012-12-01 Comparison of three statistical methods for establishing tentative wild-type population and epidemiological cutoff values for echinocandins, amphotericin B, flucytosine, and six Candida species as determined by the colorimetric sensititre yeastone method39213926, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41236]], camposKey:0732-8893 2012-12-01 Molecular epidemiology of methicillin-resistant Staphylococcus aureus in a Spanish hospital over a 4-year period: Clonal replacement, decreased antimicrobial resistance, and identification of community-acquired and livestock-associated clones332337, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41239]], camposKey:0305-7453 2012-05-01 Epidemiology, species distribution and in vitro antifungal susceptibility of fungaemia in a Spanish multicentre prospective survey11811187, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=56051]], camposKey:1697-090X 2012-01-01 Absceso periamigdalino causado por Neisseria meningitidis5456, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=22704]], camposKey:0300-8932 2012-01-01 Nanopartículas derivadas de válvula aórtica: sin evidencias de vida813818, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41240]], camposKey:0066-4804 2011-12-01 Prospective multicenter study of the epidemiology, molecular identification, and antifungal susceptibility of Candida parapsilosis, Candida orthopsilosis, and Candida metapsilosis isolated from patients with candidemia55905596, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=22707]], camposKey:1130-1406 2011-01-01 Valoración de la epidemiología de las fungemias y de la sensibilidad al fluconazol de los aislamientos de hemocultivos en los últimos 10 años en España: resultados del estudio Fungemyca9199, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41241]], camposKey:0163-4453 2008-11-01 Influence of brucellosis history on serological diagnosis and evolution of patients with acute brucellosis397403, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41242]], camposKey:0213-005X 2008-05-01 Staphylococcus spp. in Spain: Present situation and evolution of antimicrobial resistance (1986-2006) Staphylococcus spp. en España: Situación actual y evolución de la resistencia a antimicrobianos (1986-2006)269277, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=43256]], camposKey:0195-668X 2008-02-01 Association between self-replicating calcifying nanoparticles and aortic stenosis: A possible link to valve calcification371376, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41243]], camposKey:0214-3429 2007-06-01 Evolution of the antimicrobial resistance of Pseudomonas aeruginosa in Spain: Second National Study (2003)222229, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41244]], camposKey:0213-005X 2007-01-01 Seroprevalence of viral hepatitis in a representative general population of an urban public health area in Castilla y León (Spain) Seroprevalencia de las hepatitis virales en población general representativa de una zona básica de salud urbana en Castilla y León317323, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41245]], camposKey:0732-8893 2006-01-01 Utility of an immunocapture-agglutination test and an enzyme-linked immunosorbent assay test against cytosolic proteins from Brucella melitensis B115 in the diagnosis and follow-up of human acute brucellosis2735, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41246]], camposKey:0002-9637 2004-01-01 Seroepidemiologic study of Leishmania infantum infection in Castilla-Leon, Spain403406, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=43250]], camposKey:0924-8579 2004-01-01 Susceptibility of the Acinetobacter calcoaceticus-A. baumannii complex to imipenem, meropenem, sulbactam and colistin487493, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41248]], camposKey:0928-8244 2003-03-20 Serologic evidence of human infection by Francisella tularensis in the population of Castilla y León (Spain) prior to 1997165169, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=43258]], camposKey:0167-7012 2003-01-01 Identification of species of Brucella using Fourier transform infrared spectroscopy121131, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=14878]], camposKey:0025-7753 2003-01-01 Prevalencia de anticuerpos frente a Francisella tularensis en la población de Castilla y León con anterioridad a 19979798, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41249]], camposKey:0213-005X 2003-01-01 Seroprevalence of infection due to Echinococcus granulosus in the population of Castilla and León (Spain) Seroprevalencia de infección por Echinococcus granulosus en la población de Castilla y León563567, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41247]], camposKey:0732-8893 2003-01-01 Utility of a commercial immunoblot kit (BAG-Borrelia blot) in the diagnosis of the preliminary stages of Lyme disease321329, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=19821]], camposKey:0210-6523 2001-01-01 Evidencia serológica de infección humana por francisella tularensis en la provincia de Valladolid con anterioridad al brote epidémico de 1997219230, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41250]], camposKey:0095-1137 2000-12-01 Evaluation of an immunocapture-agglutination test (brucellacapt) for serodiagnosis of human brucellosis40004005, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41251]], camposKey:0025-7753 2000-01-01 Laboratory diagnosis and serologic evolution of patients with tularemia Diagnóstico de laboratorio y evolución serológica de pacientes con tularemia407410, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41252]], camposKey:0732-8893 1999-01-01 Evaluation of six serological tests in diagnosis and postoperative control of pulmonary hydatid disease patients255262, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41253]], camposKey:0934-9723 1998-09-28 Clinical evaluation of a commercial ligase-based gene amplification method for detection of Mycobacterium tuberculosis371376, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41254]], camposKey:0025-7753 1998-05-23 Genotypes of hepatitis C virus: Their relationship with risk factors, the severity of liver disease, and the serologic response Genotipos del virus de la hepatitis C: Relación con los factores de riesgo, con la gravedad de la enfermedad hepática y con la respuesta serológica681686, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41255]], camposKey:0213-005X 1998-03-01 Variants of the hepatitis C virus in different risk groups. Comparative study of one genotyping and one serotyping method Variantes del virus de la hepatitis C en diferentes grupos de riesgo. Estudio comparativo de un metodo de genotipificacion y otro de serotipificacion111117, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=78251]], camposKey:0025-7753 1998-01-01 Genotipos del virus de la hepatitis C: relación con los factores de riesgo con la gravedad de la enfermedad hepática y con la respuesta serológica681686, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41256]], camposKey:1198-743X 1997-01-01 Relation of hepatitis C virus genotypes to risk factors and hepatic disease in Spanish patients647652, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=22705]], camposKey:0210-6523 1996-01-01 Infecciones transmitidas por garrapatas: Una patología emergente143149, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41257]], camposKey:0213-005X 1995-01-01 Hepatitis E virus: Enterically transmitted non A non B hepatitis Hepatitis E: Hepatitis no A no B de transmisión entérica4549, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=39170]], camposKey:0213-005X 1993-01-01 A three year study of the electrophoretic RNA patterns of rotavirus in Valladolid (Spain) Estudio de tres años de los patrones de electroforesis de ARN de rotavirus en Valladolid309313, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=69201]], camposKey:0213-005X 1993-01-01 A three year study of the electrophoretic RNA patterns of rotavirus in Valladolid (Spain) ESTUDIO DE 3 ANOS DE LOS PATRONES DE ELECTROFORESIS DE ARN DE ROTAVIRUS EN VALLADOLID309313, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41258]], camposKey:0148-5717 1993-01-01 Influence of syphilis in hepatitis B transmission in a cohort of female prostitutes257261, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41259]], camposKey:0392-2990 1992-01-01 Infection by hepatitis B and C virus in non-intravenous drug using female prostitutes in Spain656659, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41260]], camposKey:0148-5717 1992-01-01 Prevalence of anti-hepatitis c virus antibodies in positive fta-abs non-drug abusing female prostitutes in spain3940, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=43247]], camposKey:0034-8899 1991-01-01 Age and sex distribution of sexually transmitted diseases in Valladolid. A study of 5076 cases Distribución por edad y sexo de las enfermedades de transmisión sexual en Valladolid. Estudio de 5.076 casos.247258, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=42656]], camposKey:0210-6523 1991-01-01 Borreliosis de Lyme6571, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=14888]], camposKey:0034-8899 1991-01-01 Distribución por edad y sexo de las enfermedades de transmisión sexual en Valladolid: estudio de 5076 casos247258, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41261]], camposKey:0213-4101 1991-01-01 Inhibition of the degranulation and myeloperoxidase activity of human polymorphonuclear neutrophils by Brucella melitensis.113119, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=39178]], camposKey:0213-005X 1990-12-01 Borrelia burgdorferi antibodies in a group of Valladolid population663664, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=39180]], camposKey:0213-4829 1990-01-01 Seroepidemiology of the hepatitis B virus (HBV) and hepatitis delta virus (HDV) infection in a penitentiary population Seroepidemiología de la infección por el Virus de la Hepatitis B (VHB) y Virus de la Hepatitis Delta (VHD) en una población reclusa190194, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=83411]], camposKey:0213-4829 1990-01-01 Seroepidemiology of the hepatitis B virus (HBV) and hepatitis delta virus (HDV) infection in a penitentiary population SEROEPIDEMIOLOGIA DE LA INFECCION POR VIRUS DE LA HEPATITIS B (VHB)Y VIRUS DE LA HEPATITIS DELTA (VHD) EN UNA POBLACION RECLUSA190194, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41262]], camposKey:0214-3429 1989-12-01 Effect of some antibiotics on the function of PMNs after ingestion of Brucella EFECTO DE ALGUNOS ANTIBIOTICOS SOBRE LAS FUNCIONES DE LOS PMN TRAS LA INGESTION DE BRUCELLA249253, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=39182]], camposKey:1120-009X 1989-07-01 Influence of doxycycline, streptomycin, cotrimoxazole and rifamycin on the functions of normal human neutrophils against Brucella melitensis.429431, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41702]], camposKey:0025-7753 1988-09-17 Erythema chronicum migrans caused by Borrelia burgdorferi Eritema crónico migratorio por Borrelia burgdorferi.297299, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41263]], camposKey:0722-2211 1986-02-01 Diagnosis of Gardnerella vaginalis infection by an enzyme-linked immunosorbent assay4648, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=69923]], camposKey:0365-6691 1983-01-01 Estudio del cultivo y el frotis en las conjuntivitis.4954, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=61606]], camposKey:0014-2565 1981-01-01 Zinc and copper in acute myocardial infarction and its correlation with enzymatic activity Cinc y cobre en el infarto agudo de miocardio y su correlación con la actividad enzimática.153155][CapitolsLlib{id=com.sigma.fs3.argos.domain.gpc.GpcCapitolsLlibPK[ifcactivitat=CAP, ifccomptador=14828]},camposKey: 585 597 Microbiological Quality in Cosmetics 0444635084Analysis of Cosmetic Products 1 2017-10-01 -, CapitolsLlib{id=com.sigma.fs3.argos.domain.gpc.GpcCapitolsLlibPK[ifcactivitat=CAP, ifccomptador=21022]},camposKey: 131 152 Brucelosis y Fiebre Tifoidea 84-8174-172-8Microbiología Médica, Vol 2. Microbiología Clínica 1 1996-01-01 Mosby, CapitolsLlib{id=com.sigma.fs3.argos.domain.gpc.GpcCapitolsLlibPK[ifcactivitat=CAP, ifccomptador=29467]},camposKey: 343 350 Mecanismos de supervivencia intracelular en Brucella 8477626715Estudios de Pediatría 1 1996-01-01 Secretariado de Publicaciones e Intercambio Científico ][][][][][][][][][][][com.sigma.fs3.argos.domain.gpc.GpcTesis[id=com.sigma.fs3.argos.domain.gpc.GpcTesisPK[ifcactivitat=TES, ifccomptador=2145639226]], com.sigma.fs3.argos.domain.gpc.GpcTesis[id=com.sigma.fs3.argos.domain.gpc.GpcTesisPK[ifcactivitat=TES, ifccomptador=2145638470]], com.sigma.fs3.argos.domain.gpc.GpcTesis[id=com.sigma.fs3.argos.domain.gpc.GpcTesisPK[ifcactivitat=TES, ifccomptador=2145634759]], com.sigma.fs3.argos.domain.gpc.GpcTesis[id=com.sigma.fs3.argos.domain.gpc.GpcTesisPK[ifcactivitat=TES, ifccomptador=2145624067]], com.sigma.fs3.argos.domain.gpc.GpcTesis[id=com.sigma.fs3.argos.domain.gpc.GpcTesisPK[ifcactivitat=TES, ifccomptador=69898]], com.sigma.fs3.argos.domain.gpc.GpcTesis[id=com.sigma.fs3.argos.domain.gpc.GpcTesisPK[ifcactivitat=TES, ifccomptador=2145624627]]][][][][][][][][com.sigma.investigacion.cawdos.utilidades.CongresoYSusAsociaciones@3e9c46ee][][com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@63dd82, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@63eb39, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@63ec17, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@63db4f, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@63eb7e, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@63eb22, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@63da4c, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@63d92d, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@5d3d90, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@63db14, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@63ea2b, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@63db27, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@63de42, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@63d59e, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@63d50c, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@373ed2, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@63e560, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@63e4cc, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@63e492, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@373ad2, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@63debe, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@63e5c0, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@63da93, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@63dc86, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@63d834, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@63db1d, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@373958, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@63dc2b, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@63db95][][][][][][][][com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@460891], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@4138df], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@413abf]][][][][][][][]